Management of Rhegmatogenous Retinal Detachment during COVID-19 Pandemic
Adel G. AlAkeely1, *, Abeer Habeeb2
Identifiers and Pagination:Year: 2021
First Page: 77
Last Page: 79
Publisher Id: TOCOVIDJ-1-77
Article History:Received Date: 25/2/2021
Revision Received Date: 24/5/2021
Acceptance Date: 21/6/2021
Electronic publication date: 17/09/2021
Collection year: 2021
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: (https://creativecommons.org/licenses/by/4.0/legalcode). This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Patients with primary Rhuegmatougenous Retinal detachment during COVID-19 pandemic were more likely to present late, have macula involving disease secondary and to show poor visual outcomes. Pneumatic Retinopexy (PR) is a procedure that eliminates the need for admission and limits the duration of contact with patients. Hence, more feasible during periods of shortage in hospital beds and medical personnel in the pandemic. In our experience, we successfully performed pneumatic retinopexy on two confirmed COVID-19 cases with favourable visual outcomes. We would recommend retina surgeons be familiar with such procedure as it may be a good alternative to conventional treatment while minimizing the risk of transmitting COVID-19.